Search Articles and Web Sources

Search Results

In this project

Raising The Bar: Arena — multiplayer HL2 Beta

https://sudonull.com/raising-the-bar-arena-multiplayer-hl2-beta

Learn about the new mod Raising The Bar: Arena with P2P and servers. Seven maps, AI bots, HL2 Beta setting. Release details 2026 for Half-Life fans.

KMP for AI agents: experience on 4 platforms

https://sudonull.com/kmp-for-ai-agents-experience-on-4-platforms

Breakdown of pros and cons of Kotlin Multiplatform for AI agents: release builds macOS, library conflicts, implementation without frameworks. Practical tips for middle/senior dev. Learn the pitfalls.

AI-agent Soyuz open source: security and KMP

https://sudonull.com/ai-agent-soyuz-open-source-security-and-kmp

Explore the desktop AI-agent Soyuz: open source project on Kotlin Multiplatform with a focus on security. Rejection of MCP, task graphs, GigaChat support. Download the source code and integrate into projects.

Rendering 3D apartments in the browser on Three.js

https://sudonull.com/rendering-3d-apartments-in-the-browser-on-three-js

Learn how to render procedural 3D apartments with multiplayer on Next.js + Three.js. Optimizations, avatars, lighting without glTF. For middle/senior dev.

AI Setup for Humor: Config and 7 Languages

https://sudonull.com/ai-setup-for-humor-config-and-7-languages

Learn how to set up Claude for humor via Humor Guide: contrast, tones, adaptation. Example data-site on Go+D3.js. Instructions for middle/senior dev.

From other projects

Ligue 1 Final Day Moved to Sunday 17 May Multiplex

https://lrivo.com/ligue-1-final-day-moved-to-sunday-17-may-multiplex

Ligue 1 matchday 34 shifts to Sunday 17 May with simultaneous 21:00 kick-offs. See how the new schedule impacts PSG, Lens, Strasbourg and your viewing plans.

Tottenham Summer Transfer Plans: Major Squad Overhaul Expected

https://lrivo.com/tottenham-summer-transfer-plans-major-squad-overhaul-expected

Reports indicate Tottenham Hotspur will offload multiple stars this summer, including Cristian Romero. Learn about the potential exits and squad rebuild plans.

CHECK Token Explained: How Checkmate's Economy Works

https://ymaho.com/check-token-explained-how-checkmate-s-economy-works

Understand how Checkmate's CHECK token creates a sustainable gaming economy across multiple games. Learn about supply, rewards, and risks.

Nike World Cup Jersey Shoulder Problem: 2026 Kit Issues Explained

https://lrivo.com/nike-world-cup-jersey-shoulder-problem-2026-kit-issues-explained

Learn about Nike's 2026 World Cup jersey shoulder seam problems affecting multiple national teams. Get details on fan reactions and Nike's response.

Rangers & Dundee Utd: Key Player Injury Updates

https://lrivo.com/rangers-dundee-utd-key-player-injury-updates

Get the latest team news for Rangers and Dundee United, including key returns and multiple injury absences ahead of their upcoming match. Understand the impact on squad selection and game strategy.

How Does Compound Interest Work in Investing? Full Guide

https://ymaho.com/how-does-compound-interest-work-in-investing-full-guide

Learn how does compound interest work in investing, how it multiplies wealth, and why time beats timing. Discover the Rule of 72, myths, and practical steps to start compounding today.

MLS Goalkeeper's Own Goal in Wild Toronto Comeback

https://lrivo.com/mls-goalkeeper-s-own-goal-in-wild-toronto-comeback

Experience the MLS drama as Toronto FC stages a stunning 3-2 comeback against Colorado Rapids, fueled by a bizarre goalkeeper own goal and multiple red cards. Dive into the match details now!

SpaceX IPO: the largest offering in history and risks

https://ymaho.com/spacex-ipo-the-largest-offering-in-history-and-risks

SpaceX conducted the largest IPO in history, raising $75 billion. We analyze the deal structure, multiples, lock-up period risks, and fair valuation. Read more.

Dual-action CAR-T: 100% remission in myeloma at ISCT 2026

https://ymaho.com/dual-action-car-t-100-remission-in-myeloma-at-isct-2026

ISCT 2026 data analysis: CAR-T therapy TPST-2003 showed complete response in all naive patients. Learn why this is a breakthrough, not an illusion, and what risks are hidden.

EMA approved SMA gene therapy Itvisma and a drug for MS

https://ymaho.com/ema-approved-sma-gene-therapy-itvisma-and-a-drug-for-ms

European regulator recommended Itvisma for adults with SMA and Cenrifki for secondary progressive sclerosis. Learn how a one-time injection and a pill fill gaps in neurodegeneration treatment.